Teresa Chia-Ching Chen, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma, Open-Angle | 26 | 2021 | 706 | 8.460 |
Why?
|
Nerve Fibers | 25 | 2021 | 687 | 6.990 |
Why?
|
Optic Disk | 22 | 2021 | 400 | 6.170 |
Why?
|
Retinal Ganglion Cells | 24 | 2021 | 770 | 6.030 |
Why?
|
Tomography, Optical Coherence | 39 | 2022 | 2657 | 5.130 |
Why?
|
Glaucoma | 34 | 2022 | 1159 | 5.120 |
Why?
|
Intraocular Pressure | 39 | 2021 | 1270 | 4.160 |
Why?
|
Optic Nerve Diseases | 10 | 2020 | 327 | 2.990 |
Why?
|
Cataract Extraction | 11 | 2019 | 481 | 2.650 |
Why?
|
Ophthalmology | 7 | 2022 | 508 | 2.290 |
Why?
|
Phacoemulsification | 4 | 2019 | 149 | 2.040 |
Why?
|
Glaucoma Drainage Implants | 7 | 2020 | 116 | 1.930 |
Why?
|
Glaucoma, Angle-Closure | 5 | 2019 | 189 | 1.860 |
Why?
|
Cataract | 8 | 2014 | 834 | 1.450 |
Why?
|
Retina | 10 | 2020 | 2616 | 1.420 |
Why?
|
Corneal Diseases | 8 | 2022 | 636 | 1.410 |
Why?
|
Visual Fields | 11 | 2020 | 1047 | 1.230 |
Why?
|
Aphakia, Postcataract | 6 | 2008 | 54 | 1.230 |
Why?
|
Tonometry, Ocular | 6 | 2019 | 237 | 1.200 |
Why?
|
Imaging, Three-Dimensional | 12 | 2022 | 4042 | 1.200 |
Why?
|
Artificial Organs | 3 | 2017 | 204 | 1.060 |
Why?
|
Ocular Hypertension | 3 | 2019 | 198 | 1.020 |
Why?
|
Visual Field Tests | 9 | 2020 | 383 | 0.960 |
Why?
|
Optic Disk Drusen | 2 | 2017 | 35 | 0.940 |
Why?
|
Vision Disorders | 5 | 2020 | 1058 | 0.900 |
Why?
|
Prostheses and Implants | 5 | 2022 | 1387 | 0.880 |
Why?
|
Visual Acuity | 13 | 2021 | 2530 | 0.860 |
Why?
|
Filtering Surgery | 2 | 2014 | 35 | 0.840 |
Why?
|
Ciliary Body | 4 | 2021 | 173 | 0.820 |
Why?
|
Conjunctival Diseases | 1 | 2022 | 122 | 0.770 |
Why?
|
Prosthesis Implantation | 4 | 2022 | 642 | 0.750 |
Why?
|
Anterior Chamber | 2 | 2013 | 197 | 0.720 |
Why?
|
beta-Alanine | 1 | 2020 | 74 | 0.720 |
Why?
|
Corneal Edema | 1 | 2020 | 52 | 0.720 |
Why?
|
Eye Foreign Bodies | 1 | 2020 | 55 | 0.700 |
Why?
|
Low Tension Glaucoma | 2 | 2016 | 22 | 0.700 |
Why?
|
Artifacts | 3 | 2020 | 1904 | 0.700 |
Why?
|
Laser Therapy | 3 | 2019 | 1072 | 0.700 |
Why?
|
Cornea | 5 | 2022 | 1524 | 0.680 |
Why?
|
Endophthalmitis | 4 | 2013 | 262 | 0.670 |
Why?
|
Microscopy, Acoustic | 2 | 2016 | 45 | 0.670 |
Why?
|
Benzoates | 1 | 2020 | 217 | 0.660 |
Why?
|
Keratoplasty, Penetrating | 1 | 2019 | 155 | 0.660 |
Why?
|
Exfoliation Syndrome | 3 | 2014 | 110 | 0.650 |
Why?
|
Uveal Diseases | 2 | 2012 | 45 | 0.650 |
Why?
|
Anterior Eye Segment | 3 | 2005 | 152 | 0.640 |
Why?
|
Epithelium, Corneal | 1 | 2020 | 247 | 0.610 |
Why?
|
Xanthogranuloma, Juvenile | 1 | 2016 | 17 | 0.580 |
Why?
|
Iris | 2 | 2016 | 239 | 0.560 |
Why?
|
Iris Diseases | 1 | 2016 | 40 | 0.560 |
Why?
|
Photography | 2 | 2017 | 520 | 0.550 |
Why?
|
ROC Curve | 7 | 2017 | 3527 | 0.550 |
Why?
|
Academies and Institutes | 2 | 2018 | 317 | 0.550 |
Why?
|
Aniridia | 2 | 2008 | 37 | 0.550 |
Why?
|
Diagnostic Techniques, Ophthalmological | 4 | 2017 | 245 | 0.550 |
Why?
|
Blister | 2 | 2013 | 86 | 0.510 |
Why?
|
Laser Coagulation | 1 | 2017 | 326 | 0.500 |
Why?
|
Quinoxalines | 3 | 2014 | 290 | 0.500 |
Why?
|
Prosthesis Failure | 1 | 2020 | 1206 | 0.500 |
Why?
|
Refraction, Ocular | 2 | 2013 | 182 | 0.480 |
Why?
|
Pseudophakia | 1 | 2013 | 62 | 0.470 |
Why?
|
Postoperative Complications | 13 | 2019 | 15295 | 0.450 |
Why?
|
Sentinel Surveillance | 1 | 2015 | 281 | 0.450 |
Why?
|
Clonidine | 2 | 2005 | 164 | 0.440 |
Why?
|
Adrenergic alpha-Agonists | 2 | 2005 | 177 | 0.440 |
Why?
|
Corneal Stroma | 1 | 2013 | 174 | 0.420 |
Why?
|
Area Under Curve | 4 | 2017 | 1654 | 0.420 |
Why?
|
Trabeculectomy | 7 | 2014 | 160 | 0.410 |
Why?
|
Endoscopy | 2 | 2019 | 1785 | 0.410 |
Why?
|
Antihypertensive Agents | 2 | 2020 | 2046 | 0.410 |
Why?
|
Prostaglandins, Synthetic | 1 | 2011 | 21 | 0.410 |
Why?
|
Lens Implantation, Intraocular | 1 | 2013 | 192 | 0.410 |
Why?
|
Humans | 94 | 2022 | 744343 | 0.390 |
Why?
|
Ophthalmic Solutions | 3 | 2014 | 317 | 0.380 |
Why?
|
Cross-Sectional Studies | 12 | 2020 | 25043 | 0.360 |
Why?
|
Hyphema | 2 | 2007 | 26 | 0.360 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2012 | 312 | 0.360 |
Why?
|
Aged | 35 | 2020 | 163280 | 0.350 |
Why?
|
Bupropion | 1 | 2012 | 303 | 0.350 |
Why?
|
Middle Aged | 33 | 2020 | 213383 | 0.350 |
Why?
|
Sensitivity and Specificity | 8 | 2017 | 14722 | 0.330 |
Why?
|
Female | 51 | 2020 | 380194 | 0.320 |
Why?
|
Retinal Vessels | 3 | 2014 | 772 | 0.310 |
Why?
|
Uveitis | 1 | 2011 | 375 | 0.310 |
Why?
|
Male | 46 | 2020 | 350118 | 0.310 |
Why?
|
False Positive Reactions | 3 | 2016 | 981 | 0.300 |
Why?
|
Myopia | 2 | 2016 | 254 | 0.300 |
Why?
|
Medical Errors | 1 | 2015 | 1297 | 0.280 |
Why?
|
Eye Injuries | 2 | 2007 | 245 | 0.280 |
Why?
|
Retrospective Studies | 23 | 2022 | 77449 | 0.270 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15076 | 0.270 |
Why?
|
Gonioscopy | 3 | 2013 | 157 | 0.270 |
Why?
|
Aged, 80 and over | 16 | 2020 | 57776 | 0.270 |
Why?
|
Software | 1 | 2019 | 4443 | 0.250 |
Why?
|
Prosthesis Design | 2 | 2019 | 2110 | 0.250 |
Why?
|
Blindness | 2 | 2015 | 617 | 0.250 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2212 | 0.250 |
Why?
|
Clinical Competence | 2 | 2018 | 4687 | 0.240 |
Why?
|
Technology Assessment, Biomedical | 2 | 2018 | 306 | 0.240 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2291 | 0.230 |
Why?
|
Conjunctiva | 2 | 2022 | 494 | 0.230 |
Why?
|
Chlorpromazine | 1 | 2002 | 111 | 0.210 |
Why?
|
Macular Degeneration | 2 | 2008 | 980 | 0.210 |
Why?
|
Adult | 28 | 2020 | 214055 | 0.200 |
Why?
|
Dopamine Antagonists | 1 | 2002 | 296 | 0.200 |
Why?
|
Reproducibility of Results | 7 | 2019 | 19905 | 0.190 |
Why?
|
Fructose | 1 | 2003 | 288 | 0.190 |
Why?
|
Wounds, Nonpenetrating | 1 | 2007 | 794 | 0.190 |
Why?
|
Algorithms | 4 | 2019 | 13881 | 0.180 |
Why?
|
Prospective Studies | 8 | 2021 | 53288 | 0.180 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2022 | 349 | 0.170 |
Why?
|
Technology | 1 | 2022 | 305 | 0.170 |
Why?
|
Intraoperative Complications | 2 | 2018 | 1198 | 0.170 |
Why?
|
rho-Associated Kinases | 1 | 2020 | 279 | 0.170 |
Why?
|
Benchmarking | 2 | 2016 | 1042 | 0.160 |
Why?
|
Child | 12 | 2019 | 77709 | 0.150 |
Why?
|
Optic Nerve | 1 | 2021 | 554 | 0.150 |
Why?
|
Abnormalities, Multiple | 3 | 2016 | 1416 | 0.150 |
Why?
|
Aqueous Humor | 2 | 2010 | 161 | 0.140 |
Why?
|
Geographic Atrophy | 1 | 2017 | 66 | 0.140 |
Why?
|
Homocystinuria | 1 | 2016 | 67 | 0.140 |
Why?
|
False Negative Reactions | 1 | 2017 | 588 | 0.140 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 2017 | 123 | 0.140 |
Why?
|
Dark Adaptation | 1 | 2017 | 219 | 0.140 |
Why?
|
Withholding Treatment | 1 | 2020 | 599 | 0.140 |
Why?
|
Infant | 8 | 2014 | 35136 | 0.130 |
Why?
|
Suture Techniques | 1 | 2020 | 798 | 0.130 |
Why?
|
Wet Macular Degeneration | 1 | 2017 | 145 | 0.130 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13989 | 0.130 |
Why?
|
Fetal Diseases | 2 | 2010 | 903 | 0.130 |
Why?
|
Aging | 1 | 2013 | 8664 | 0.120 |
Why?
|
Organ Size | 1 | 2019 | 2252 | 0.120 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2014 | 87 | 0.110 |
Why?
|
Anticonvulsants | 1 | 2003 | 1916 | 0.110 |
Why?
|
Anesthetics | 1 | 2019 | 539 | 0.110 |
Why?
|
Adolescent | 10 | 2016 | 85781 | 0.110 |
Why?
|
Injections | 2 | 2009 | 840 | 0.110 |
Why?
|
Child, Preschool | 7 | 2014 | 41006 | 0.110 |
Why?
|
Biometry | 1 | 2016 | 558 | 0.110 |
Why?
|
Antigens, Differentiation | 2 | 2008 | 927 | 0.110 |
Why?
|
Models, Theoretical | 2 | 2020 | 3589 | 0.100 |
Why?
|
Lenses, Intraocular | 1 | 2013 | 140 | 0.100 |
Why?
|
Intravitreal Injections | 1 | 2013 | 344 | 0.100 |
Why?
|
Surgical Flaps | 1 | 2020 | 1640 | 0.100 |
Why?
|
Risk Management | 1 | 2015 | 571 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2016 | 39050 | 0.100 |
Why?
|
Task Performance and Analysis | 1 | 2015 | 780 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2019 | 63114 | 0.090 |
Why?
|
Pilot Projects | 2 | 2017 | 8324 | 0.090 |
Why?
|
Rhabdomyoma | 1 | 2010 | 57 | 0.090 |
Why?
|
Ethmoid Sinus | 1 | 2010 | 58 | 0.090 |
Why?
|
Refractometry | 2 | 2007 | 56 | 0.090 |
Why?
|
Eye Infections, Bacterial | 1 | 2013 | 235 | 0.090 |
Why?
|
Reference Values | 3 | 2013 | 4982 | 0.090 |
Why?
|
Amniocentesis | 1 | 2009 | 116 | 0.090 |
Why?
|
Hemorrhage | 1 | 2021 | 3461 | 0.080 |
Why?
|
Massachusetts | 3 | 2018 | 8663 | 0.080 |
Why?
|
Elastin | 1 | 2010 | 308 | 0.080 |
Why?
|
Functional Laterality | 1 | 2016 | 2290 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1179 | 0.080 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2009 | 326 | 0.080 |
Why?
|
Postoperative Period | 1 | 2013 | 1842 | 0.080 |
Why?
|
Likelihood Functions | 1 | 2012 | 1005 | 0.080 |
Why?
|
Maxillary Sinus | 1 | 2010 | 180 | 0.080 |
Why?
|
Ascites | 1 | 2010 | 344 | 0.080 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2009 | 373 | 0.080 |
Why?
|
Comparative Genomic Hybridization | 1 | 2009 | 496 | 0.080 |
Why?
|
Retinoscopes | 1 | 2007 | 3 | 0.080 |
Why?
|
Lacrimal Apparatus | 1 | 2010 | 225 | 0.080 |
Why?
|
Models, Biological | 2 | 2015 | 9583 | 0.080 |
Why?
|
Risk Factors | 7 | 2014 | 72290 | 0.080 |
Why?
|
Vitreous Body | 1 | 2009 | 389 | 0.070 |
Why?
|
Blood | 2 | 2007 | 598 | 0.070 |
Why?
|
Internship and Residency | 2 | 2018 | 5788 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8642 | 0.070 |
Why?
|
Pain | 1 | 2002 | 4986 | 0.070 |
Why?
|
Safety | 2 | 2002 | 1186 | 0.070 |
Why?
|
Retinal Diseases | 1 | 2013 | 683 | 0.070 |
Why?
|
Eye Enucleation | 1 | 2006 | 128 | 0.070 |
Why?
|
Graft Survival | 1 | 2016 | 3737 | 0.070 |
Why?
|
Single-Blind Method | 1 | 2009 | 1590 | 0.070 |
Why?
|
Equipment Design | 3 | 2009 | 3582 | 0.070 |
Why?
|
Birefringence | 4 | 2007 | 56 | 0.070 |
Why?
|
Lens Capsule, Crystalline | 1 | 2005 | 43 | 0.070 |
Why?
|
Immunization, Passive | 1 | 2008 | 623 | 0.070 |
Why?
|
Rectum | 1 | 2010 | 904 | 0.070 |
Why?
|
Iridectomy | 1 | 2005 | 49 | 0.070 |
Why?
|
Trauma Severity Indices | 1 | 2007 | 481 | 0.070 |
Why?
|
Regional Blood Flow | 2 | 2006 | 1525 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 3 | 2013 | 2038 | 0.060 |
Why?
|
Curriculum | 1 | 2018 | 3605 | 0.060 |
Why?
|
Photoreceptor Cells | 1 | 2006 | 244 | 0.060 |
Why?
|
Choroidal Neovascularization | 1 | 2008 | 343 | 0.060 |
Why?
|
Wound Healing | 2 | 2013 | 2785 | 0.060 |
Why?
|
Ophthalmoscopes | 1 | 2004 | 23 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2013 | 3508 | 0.060 |
Why?
|
Eye Proteins | 1 | 2008 | 646 | 0.060 |
Why?
|
Scleral Diseases | 1 | 2004 | 22 | 0.060 |
Why?
|
Disease Progression | 2 | 2019 | 13284 | 0.060 |
Why?
|
Antibodies, Monoclonal | 4 | 2009 | 9274 | 0.060 |
Why?
|
Photometry | 1 | 2004 | 58 | 0.060 |
Why?
|
Translocation, Genetic | 1 | 2009 | 1420 | 0.060 |
Why?
|
Orbital Neoplasms | 1 | 2006 | 225 | 0.060 |
Why?
|
Patient Care Team | 1 | 2015 | 2531 | 0.060 |
Why?
|
Uvea | 1 | 2003 | 31 | 0.060 |
Why?
|
Ophthalmoscopy | 1 | 2004 | 176 | 0.060 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.060 |
Why?
|
Homeostasis | 1 | 2014 | 3340 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2003 | 253 | 0.050 |
Why?
|
Tuberous Sclerosis | 1 | 2010 | 1029 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2008 | 2421 | 0.050 |
Why?
|
Heart Rate | 2 | 2005 | 4091 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2012 | 15519 | 0.050 |
Why?
|
Cytoskeletal Proteins | 1 | 2008 | 1364 | 0.050 |
Why?
|
History, 20th Century | 1 | 2009 | 2740 | 0.050 |
Why?
|
Choroid | 1 | 2003 | 322 | 0.050 |
Why?
|
United States | 4 | 2018 | 69872 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2849 | 0.040 |
Why?
|
Twins, Dizygotic | 2 | 2010 | 236 | 0.040 |
Why?
|
Glycoproteins | 1 | 2008 | 2263 | 0.040 |
Why?
|
Antigens, CD | 2 | 2008 | 4026 | 0.040 |
Why?
|
Sex Factors | 1 | 2013 | 10397 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2005 | 12026 | 0.040 |
Why?
|
Age Factors | 2 | 2006 | 18370 | 0.040 |
Why?
|
Orbit | 1 | 2002 | 426 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2012 | 3748 | 0.040 |
Why?
|
Ovarian Neoplasms | 2 | 2008 | 4838 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15540 | 0.040 |
Why?
|
Cysts | 1 | 2004 | 678 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15226 | 0.040 |
Why?
|
Blood Pressure | 2 | 2005 | 8554 | 0.040 |
Why?
|
Melanoma | 2 | 2008 | 5510 | 0.040 |
Why?
|
Jaw Abnormalities | 1 | 2016 | 27 | 0.040 |
Why?
|
Heart Murmurs | 1 | 2016 | 94 | 0.040 |
Why?
|
Carcinoma | 1 | 2008 | 2375 | 0.030 |
Why?
|
Young Adult | 2 | 2013 | 56430 | 0.030 |
Why?
|
Funnel Chest | 1 | 2016 | 71 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2017 | 391 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2003 | 901 | 0.030 |
Why?
|
Cancer Vaccines | 1 | 2003 | 1023 | 0.030 |
Why?
|
Time Factors | 3 | 2007 | 40075 | 0.030 |
Why?
|
Retinal Neurons | 1 | 2015 | 66 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2007 | 3327 | 0.030 |
Why?
|
Acid-Base Equilibrium | 1 | 2014 | 185 | 0.030 |
Why?
|
Homocysteine | 1 | 2016 | 647 | 0.030 |
Why?
|
Triamcinolone Acetonide | 1 | 2013 | 101 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2006 | 2861 | 0.030 |
Why?
|
Preoperative Period | 1 | 2014 | 549 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8949 | 0.030 |
Why?
|
Aptamers, Nucleotide | 1 | 2013 | 166 | 0.020 |
Why?
|
Hydrocolpos | 1 | 2010 | 2 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2012 | 535 | 0.020 |
Why?
|
Seizures | 1 | 2003 | 2859 | 0.020 |
Why?
|
Anthropometry | 2 | 2006 | 1350 | 0.020 |
Why?
|
Polydactyly | 1 | 2010 | 57 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2014 | 1423 | 0.020 |
Why?
|
Potassium | 1 | 2014 | 1336 | 0.020 |
Why?
|
Ultrasonography | 1 | 2003 | 5985 | 0.020 |
Why?
|
Posture | 1 | 2014 | 958 | 0.020 |
Why?
|
Eye Infections | 1 | 2010 | 64 | 0.020 |
Why?
|
Uterine Diseases | 1 | 2010 | 135 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2010 | 8863 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2010 | 399 | 0.020 |
Why?
|
Gene Duplication | 1 | 2009 | 329 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 20947 | 0.020 |
Why?
|
Pregnancy | 4 | 2010 | 29144 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2016 | 1848 | 0.020 |
Why?
|
Genotype | 2 | 2012 | 12951 | 0.020 |
Why?
|
Prognosis | 2 | 2004 | 29063 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 35421 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2006 | 242 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2007 | 498 | 0.020 |
Why?
|
Vagina | 1 | 2010 | 825 | 0.020 |
Why?
|
Calibration | 1 | 2007 | 816 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2005 | 25625 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 903 | 0.020 |
Why?
|
Regression Analysis | 1 | 2014 | 6459 | 0.020 |
Why?
|
Prosthesis-Related Infections | 1 | 2010 | 538 | 0.010 |
Why?
|
Fluorescein Angiography | 1 | 2008 | 940 | 0.010 |
Why?
|
Bone Density | 1 | 2016 | 3468 | 0.010 |
Why?
|
Antimetabolites | 1 | 2004 | 125 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3588 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 2010 | 1236 | 0.010 |
Why?
|
Mutation | 1 | 2008 | 29786 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2009 | 1813 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 1970 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 2010 | 1695 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4560 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2759 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7149 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6933 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12959 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2004 | 868 | 0.010 |
Why?
|
Light | 1 | 2007 | 1374 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3870 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2007 | 2480 | 0.010 |
Why?
|
Necrosis | 1 | 2003 | 1643 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2003 | 1284 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 21746 | 0.010 |
Why?
|
Image Enhancement | 1 | 2007 | 2921 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16365 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7181 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2008 | 2988 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2010 | 4584 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2006 | 3507 | 0.010 |
Why?
|
Recurrence | 1 | 2002 | 8340 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2003 | 4479 | 0.010 |
Why?
|
Cohort Studies | 1 | 2008 | 40561 | 0.000 |
Why?
|
Mice | 1 | 2003 | 81183 | 0.000 |
Why?
|
Animals | 1 | 2003 | 168757 | 0.000 |
Why?
|